Quick Answer
Relay Therapeutics, Inc. reported Net Income of -$276.48 million for fiscal year 2025.
Relay Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$276.48M | +18.1% |
| 2024 | -$337.71M | +1.2% |
| 2023 | -$341.97M | -17.7% |
| 2022 | -$290.51M | +20.2% |
| 2021 | -$363.87M | -594.3% |
| 2020 | -$52.41M | +30.4% |
| 2019 | -$75.31M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$74.15M | +15.8% | -5.4% |
| June 30, 2025 | -$70.38M | +23.7% | +8.7% |
| March 31, 2025 | -$77.06M | +5.3% | +12.5% |
| September 30, 2024 | -$88.11M | -34.0% | +4.5% |
| June 30, 2024 | -$92.21M | +6.4% | -13.3% |
| March 31, 2024 | -$81.39M | +13.6% | -23.8% |
| September 30, 2023 | -$65.73M | +21.9% | +33.3% |
| June 30, 2023 | -$98.50M | -28.3% | -4.5% |
- Relay Therapeutics, Inc. showed an increase of +18.1% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Relay Therapeutics, Inc.’s net income has declined by 267.1% (from -$75.31 million to -$276.48 million).
- The most recent figure is from Relay Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: